The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-Nitrophenylhydrazono)-1-benzosuberone ID: ALA609864
PubChem CID: 46226868
Max Phase: Preclinical
Molecular Formula: C17H15N3O3
Molecular Weight: 309.33
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C1/C(=N/Nc2ccc([N+](=O)[O-])cc2)CCCc2ccccc21
Standard InChI: InChI=1S/C17H15N3O3/c21-17-15-6-2-1-4-12(15)5-3-7-16(17)19-18-13-8-10-14(11-9-13)20(22)23/h1-2,4,6,8-11,18H,3,5,7H2/b19-16+
Standard InChI Key: YRKPIFKNZFBSAB-KNTRCKAVSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
2.1441 -15.3506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4591 -14.8919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4004 -14.0729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9838 -13.4896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8124 -13.6110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2287 -14.3303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0458 -14.1992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5653 -14.8408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2718 -15.6113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4545 -15.7401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9309 -15.0984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0296 -16.1663 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7438 -15.3040 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0280 -14.8939 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6919 -15.3069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6919 -16.1443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4027 -16.5533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1087 -16.1446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1087 -15.3280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3988 -14.9196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8334 -16.5647 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8334 -17.4007 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.5388 -16.1564 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
6 11 2 0
1 11 1 0
1 12 2 0
13 14 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
21 22 2 0
21 23 1 0
18 21 1 0
14 15 1 0
2 13 2 0
M CHG 2 21 1 23 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 309.33Molecular Weight (Monoisotopic): 309.1113AlogP: 3.58#Rotatable Bonds: 3Polar Surface Area: 84.60Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.41CX Basic pKa: 1.05CX LogP: 4.63CX LogD: 4.57Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.53Np Likeness Score: -1.11
References 1. Farghaly TA, Abdalla MM.. (2009) Synthesis, tautomerism, and antimicrobial, anti-HCV, anti-SSPE, antioxidant, and antitumor activities of arylazobenzosuberones., 17 (23): [PMID:19864149 ] [10.1016/j.bmc.2009.10.012 ]